glp-1 logo Physician Locator Map — Collective GNC's new GLP-1 support section

For the treatment-regimen estimand, the mean body weight reductions from baseline at 72 weeks were 15.0%, 19.5%, and 20.9% in the tirzepatide 5, 10, and 15 mg groups, respectively, versus 3.1% in the placebo group

Side effects do not directly mean muscle loss is happening, but nausea, constipation, fatigue, reflux, and low appetite can make it harder to eat enough protein and maintain resistance training

GLP-1s: Lower blood sugar Reduce appetiteso you eat less and feel fuller Promote healthy weight loss Improve metabolism Lower whole-body inflammationincluding that which affects your joints GLP-1s Target Both Metabolic and Inflammatory Pathways Recent research shows that GLP-1 medications can: Lower levels of inflammatory cytokines like TNF-alpha, IL-6, and IL-1 Restore a healthier gut microbiome and calm immune reactions Reduce fat-driven inflammationwhy losing just 510% of body weight improves autoimmune diseases Reverse insulin resistancea key link between metabolic and autoimmune disease Reduce oxidative stress, protecting organs and joint cartilage GLP-1s in RA, PsA, OA, and More: Evidence and Results Rheumatoid Arthritis Obesity increases RA risk and severity

[DOI] [PMC free article] [PubMed] [Google Scholar] 265.Seidelmann S.B., Feofanova E., Yu B., Franceschini N., Claggett B., Kuokkanen M., Puolijoki H., Ebeling T., Perola M., Salomaa V., et al

Though the mechanisms through which this drug might influence alcohol craving and consumption are not known, in theory semaglutides inhibition of the appetitive centers in the brain could lead to reduced cravings and appetite for things other than food, like alcohol and other drugs